Tandem Diabetes Care (TNDM) Amortization of Deferred Charges (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Amortization of Deferred Charges came in at $576000.0 in Q1 2026, up 14.06% YoY from $505000.0 in Q1 2025, and up 29.15% on a QoQ basis from $446000.0 in Q4 2025.
Tandem Diabetes Care (TNDM) Amortization of Deferred Charges (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 13 years of Amortization of Deferred Charges data on file, last reported at $576000.0 in Q1 2026.
- Quarterly Amortization of Deferred Charges rose 14.06% year-over-year to $576000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 0.67% YoY) and the FY2025 annual result came in at $1.9 million, down 10.96% from the prior year.
- Amortization of Deferred Charges rose to $576000.0 in Q1 2026, from $446000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $702000.0 in Q3 2023 to a low of $435000.0 in Q2 2024.
- A 5-year average of $504000.0 and a median of $498000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges soared 40.96% — and 2024, when it slipped 28.49%.
- Tracing TNDM's Amortization of Deferred Charges over 5 years: stood at $501000.0 in 2022, then retreated by 1.6% to $493000.0 in 2023, then gained by 1.83% to $502000.0 in 2024, then slipped by 11.16% to $446000.0 in 2025, then climbed by 29.15% to $576000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $576000.0 (Q1 2026), $446000.0 (Q4 2025), and $444000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 809,000.00 |
| Jun 30, 2026 | 809,000.00 |
| Mar 31, 2026 | 576,000.00 |
| Mar 31, 2026 | 576,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 465,000.00 |
| Jun 30, 2025 | 465,000.00 |
| Mar 31, 2025 | 505,000.00 |
| Mar 31, 2025 | 505,000.00 |
| Dec 31, 2024 | 502,000.00 |
| Dec 31, 2024 | 502,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Sep 30, 2024 | 502,000.00 |
| Jun 30, 2024 | 435,000.00 |
| Jun 30, 2024 | 435,000.00 |
| Mar 31, 2024 | 650,000.00 |
| Mar 31, 2024 | 650,000.00 |